Cigna Group $CI Shares Sold by Keybank National Association OH

Keybank National Association OH lessened its stake in shares of Cigna Group (NYSE:CI) by 1.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 125,478 shares of the health services provider’s stock after selling 2,457 shares during the quarter. Keybank National Association OH’s holdings in Cigna Group were worth $34,109,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Cornerstone Wealth Management LLC increased its holdings in Cigna Group by 3.7% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 1,801 shares of the health services provider’s stock worth $490,000 after acquiring an additional 65 shares during the period. Alexander Randolph Advisory Inc. lifted its stake in Cigna Group by 4.4% in the 3rd quarter. Alexander Randolph Advisory Inc. now owns 8,557 shares of the health services provider’s stock worth $2,326,000 after purchasing an additional 363 shares in the last quarter. 71 West Capital Partners boosted its holdings in Cigna Group by 6.2% in the 3rd quarter. 71 West Capital Partners now owns 2,103 shares of the health services provider’s stock valued at $572,000 after purchasing an additional 123 shares during the period. AlphaCore Capital LLC boosted its holdings in Cigna Group by 25.9% in the 3rd quarter. AlphaCore Capital LLC now owns 7,916 shares of the health services provider’s stock valued at $2,152,000 after purchasing an additional 1,626 shares during the period. Finally, Running Oak Capital LLC grew its position in shares of Cigna Group by 4.1% during the 3rd quarter. Running Oak Capital LLC now owns 38,361 shares of the health services provider’s stock valued at $10,428,000 after purchasing an additional 1,514 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Robert W. Baird set a $362.00 price target on shares of Cigna Group in a report on Friday, July 31st. Barclays increased their price objective on Cigna Group from $310.00 to $320.00 and gave the stock an “equal weight” rating in a research report on Monday. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the company from $350.00 to $320.00 in a research note on Monday, August 3rd. Sanford C. Bernstein boosted their target price on Cigna Group from $387.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Fourteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $340.80.

Insider Transactions at Cigna Group

In related news, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. This represents a 10.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE:CI opened at $301.25 on Thursday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock has a market cap of $79.38 billion, a PE ratio of 13.29, a PEG ratio of 1.13 and a beta of 0.25. The company’s fifty day moving average is $287.03 and its 200 day moving average is $282.49. Cigna Group has a 52 week low of $257.85 and a 52 week high of $318.05.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The business had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. During the same period in the prior year, the business posted $7.83 earnings per share. The company’s revenue was up 5.6% on a year-over-year basis. Research analysts anticipate that Cigna Group will post 30.72 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, December 3rd. Cigna Group’s payout ratio is 27.54%.

Latest Cigna Group News

Investors following CI have been watching these news items:

• Positive Sentiment: Barclays raised its price target for CI, indicating a more favorable analyst view; the report provided here does not specify the new target or rationale. Article: Cigna Group Stock Price Target Raised at Barclays
• Neutral Sentiment: Cigna’s foundation announced $3.45 million in grants to support housing stability and mental health services for veterans and their families. The initiative may support the company’s reputation but is not presented as a material financial development. Article: Cigna Foundation Awards Grants for Veterans
• Negative Sentiment: The latest outlook coverage says risks persist, tempering the benefit of the higher 2026 outlook. The available article details do not specify which risks are involved. Article: The Cigna Group stock gains as 2026 outlook rises, risks persist

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.